Cantel Medical Buying Siemens Sub

Medical-products maker Cantel Medical (NYSE: CMN  ) announced Monday that its Mar Cor Purification subsidiary has purchased Siemens' (NYSE: SI  ) hemodialysis water business, used in dialysis, for an undisclosed sum.

The business services 600 customers in the U.S. and Canada and generated about $9 million in revenue last year. Cantel is already a leader in the dialysis industry, providing "advanced heat-based disinfection" services to prevent and control infections.

Cantel says the purchase will further expand Mar Cor's "North American footprint" and will also be "slightly accretive" to earnings for the company in fiscal 2013. Shares of the company shed 0.6% of their value in Monday trading, closing at $29.03.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2330927, ~/Articles/ArticleHandler.aspx, 4/18/2014 5:11:18 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement